Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NEDD4L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TNFAIP8L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETFDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEPDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL27RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GXYLT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP8A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTL8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRLR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on